Study of Sargramostim in Patients With COVID-19

NCT04411680 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV-2

Interventions

DRUG: Sargramostim
DRUG: Standard of care

Sponsor

Partner Therapeutics, Inc.

Collaborators

[object Object]